| Dr Christopher Manhart, DO | |
|
1400 E Boulder St Ste 700, Colorado Springs, CO 80909 | |
| (719) 635-7172 | |
| (719) 365-7668 |
| Full Name | Dr Christopher Manhart |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 15 Years |
| Location | 1400 E Boulder St Ste 700, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508191354 | NPI | - | NPPES |
| 0166979 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uch-memorial Health System | Colorado springs, CO | Hospital |
| Uchealth Pikes Peak Regional Hospital | Woodland park, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Poudre Valley Medical Group Llc | 9638208549 | 1605 |
News Archive
More than three dozen community leaders from across the country have come together to actively engage lawmakers on the value Medicare Advantage provides to vulnerable seniors in their communities.
Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Researchers at the University of Michigan in the United States have cautioned against only using within-host minor genetic variations to resolve the genomic epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Entity Name | Poudre Valley Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366763260 PECOS PAC ID: 9638208549 Enrollment ID: O20100602000122 |
News Archive
More than three dozen community leaders from across the country have come together to actively engage lawmakers on the value Medicare Advantage provides to vulnerable seniors in their communities.
Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Researchers at the University of Michigan in the United States have cautioned against only using within-host minor genetic variations to resolve the genomic epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Manhart, DO 2695 Rocky Mountain Ave Ste 150, Loveland, CO 80538-9071 Ph: (970) 624-4034 | Dr Christopher Manhart, DO 1400 E Boulder St Ste 700, Colorado Springs, CO 80909 Ph: (719) 635-7172 |
News Archive
More than three dozen community leaders from across the country have come together to actively engage lawmakers on the value Medicare Advantage provides to vulnerable seniors in their communities.
Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Researchers at the University of Michigan in the United States have cautioned against only using within-host minor genetic variations to resolve the genomic epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
Michael Judd Burkholz, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2940 N Circle Dr, Colorado Springs, CO 80909 Phone: 719-635-7321 Fax: 719-635-2510 | |
Mrs. Rachel Elizabeth Black, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2222 N Nevada Ave Ste 4004, Colorado Springs, CO 80907 Phone: 719-471-7064 | |
William A Munson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 325 E Fontanero St, Colorado Springs Endocrine Clinic Pc, Colorado Springs, CO 80907 Phone: 719-636-3829 Fax: 719-636-1387 | |
Barbara E Johnston, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 S Union Blvd Ste 350, Colorado Springs, CO 80910 Phone: 719-633-5515 Fax: 719-365-1307 | |
Dr. Raymond L. Wahl, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2502 E Pikes Peak Ave, Colorado Springs, CO 80909 Phone: 719-630-6440 Fax: 719-228-6603 | |
Dr. Duane Ryan Spaulding, M.D., F.A.C.P. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6722 Northface Ln, Colorado Springs, CO 80919 Phone: 719-590-9338 | |
Dr. Wendy Marie Bamberg, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 S Union Blvd, Colorado Springs, CO 80910 Phone: 719-578-3199 |